Continuously monitoring more than 50,000 news publishers worldwide each day and analysing conversations across a global ...
Pathos AI has secured $365 million in a series D raise as the artificial-intelligence-powered biotech looks to fund trials of solid tumor drugs sourced from Novo Nordisk and Prelude Therapeutics. The ...
By monitoring more than 50,000 news publishers every day and mining conversations across a global network of hundreds of ...
While teaching a class on intelligence and analysis last year, I asked my graduate students why the media’s shocking picture of the drowned Syrian boy seemed to have such an incredible effect on ...
(Alliance News) - Pathos Communications PLC on Tuesday began trading on London's AIM, after raising GBP5.6 million in its initial public offering. The PR company said it completed the fundraising ...
Anyone who’s shed a tear (or a thousand) during Sarah McLachlan’s ASPCA commercial knows that as much as we might like to think of ourselves as purely logical beings, we’re often driven by our ...
NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will ...
This UK-based PR firm has a track record of raising the profiles of UK businesses, while helping them stay within reasonable budgets. Pathos Communications presents a unique approach to marketing and ...
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-enabled biotech company focused on transforming drug development in oncology, today announced the appointment of Iker Huerga as Chief ...
Why you can trust What Hi-Fi? Our expert team reviews products in dedicated test rooms, to help you make the best choice for your budget. Find out more about how we test. Few companies combine style ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results